{"content":"<li class=\"n-box-item date-title\" data-end=\"1569902399\" data-start=\"1569816000\" data-txt=\"Monday, December 23, 2019\">Monday, September 30, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3502749\" data-ts=\"1569880816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANAB\" target=\"_blank\">ANAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502749-anaptysbiominus-13_5-after-gallop-trial-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AnaptysBio -13.5% after GALLOP trial data</a></h4><ul>   <li>AnaptysBio (NASDAQ:<a href='https://seekingalpha.com/symbol/ANAB' title='AnaptysBio, Inc.'>ANAB</a>) has <font color=\"red\">slipped 13.5%</font> postmarket after posting some positive <a href=\"https://seekingalpha.com/pr/17648124-anaptysbio-reports-positive-topline-data-interim-analysis-gallop-phase-2-clinical-trial\" target=\"_blank\">topline data</a> from its interim analysis of the GALLOP Phase 2 clinical trial.</li>    <li>That analysts was conducted with the first two patients completing a 16-week ANB019 monotherapy study for treating moderate-to-severe generalized pustular psoriasis.</li>    <li>That's a chronic, life-threatening, rare inflammatory disease that has no approved therapies, the company says.</li>    <li>Enrollment is ongoing and the company expects additional clinical data and a regulatory strategy update in 2020.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502749\" data-linked=\"AnaptysBio -13.5% after GALLOP trial data\" data-tweet=\"$ANAB - AnaptysBio -13.5% after GALLOP trial data https://seekingalpha.com/news/3502749-anaptysbiominus-13_5-after-gallop-trial-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3502749-anaptysbiominus-13_5-after-gallop-trial-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502747\" data-ts=\"1569880588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VBIV\" target=\"_blank\">VBIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502747-vbi-vaccinesplus-5-ceo-buys-150k-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VBI Vaccines +5% as CEO buys 150K shares</a></h4><ul>   <li>VBI Vaccines (NASDAQ:<a href='https://seekingalpha.com/symbol/VBIV' title='VBI Vaccines Inc.'>VBIV</a>) is <font color=\"green\">up 5%</font> after hours following a <a href=\"https://seekingalpha.com/filing/4650509\" target=\"_blank\">filing</a> showing its CEO buying 150,000 shares.</li>    <li>Jeff Baxter disclosed that he bought that amount today at an average price of $0.503.</li>    <li>After the purchase, Baxter's beneficial direct ownership stands at 608,255 shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502747\" data-linked=\"VBI Vaccines +5% as CEO buys 150K shares\" data-tweet=\"$VBIV - VBI Vaccines +5% as CEO buys 150K shares https://seekingalpha.com/news/3502747-vbi-vaccinesplus-5-ceo-buys-150k-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3502747-vbi-vaccinesplus-5-ceo-buys-150k-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502745\" data-ts=\"1569879131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502745-cco-nov-iq-and-cig-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CCO, NOV, IQ and CIG among after hour movers</a></h4><div><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/CCO' title='Clear Channel Outdoor Holdings, Inc.'>CCO</a> <font color=\"green\">+17.1%</font>. <a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color=\"green\">+15.6%</font>. <a href='https://seekingalpha.com/symbol/LVGO' title='Livongo Health, Inc.'>LVGO</a> <font color=\"green\">+7.3%</font>. <a href='https://seekingalpha.com/symbol/CNNE' title='Cannae Holdings, Inc.'>CNNE</a> <font color=\"green\">+5.5%</font>. <a href='https://seekingalpha.com/symbol/PEB' title='Pebblebrook Hotel Trust'>PEB</a> <font color=\"green\">+5%</font>.</li><li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/AYRSF' title='Ayr Strategies Inc.'>OTCQX:AYRSF</a> <font color=\"red\">-18.8%</font>. <a href='https://seekingalpha.com/symbol/ANAB' title='AnaptysBio, Inc.'>ANAB</a> <font color=\"red\">-12.6%</font>. <a href='https://seekingalpha.com/symbol/CRLBF' title='Cresco Labs Inc.'>OTCQX:CRLBF</a> <font color=\"red\">-8.9%</font>. <a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc.'>IQ</a> <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/CIG' title='Companhia Energética de Minas Gerais'>CIG</a> <font color=\"red\">-4.7%</font>.</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3502745\" data-linked=\"CCO, NOV, IQ and CIG among after hour movers\" data-tweet=\"$CCO $NOV $LVGO - CCO, NOV, IQ and CIG among after hour movers https://seekingalpha.com/news/3502745-cco-nov-iq-and-cig-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3502745-cco-nov-iq-and-cig-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502736\" data-ts=\"1569877376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLNK\" target=\"_blank\">NLNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502736-newlinkminus-1_3-on-lumos-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NewLink -1.3% on Lumos merger</a></h4><ul><li>NewLink (NASDAQ:<a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a>) and Lumos Pharma <a href=\"https://seekingalpha.com/pr/17648175-newlink-genetics-lumos-pharma-enter-merger-agreement-form-biopharmaceutical-company-focused\" target=\"_blank\">sign</a> a definitive merger agreement that will result in Lumos becoming a wholly-owned subsidiary and NewLink taking on the Lumos name and new \"LUMO\" ticker.</li><li>Lumos shareholders will receive NLNK common stock shares in an exchange that will leave Lumos holders with a 50% stake in the resulting entity.</li><li>This merger is expected to provide the financial support necessary to expedite the clinical development of LUM-201 for PGHD, which could start its Phase 2b clinical trial in mid-2020.</li><li>The deal is expected to close in Q1 2020.</li><li>NLNK shares are <font color=\"red\">down 1.3%</font> after hours to $1.57.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502736\" data-linked=\"NewLink -1.3% on Lumos merger\" data-tweet=\"$NLNK - NewLink -1.3% on Lumos merger https://seekingalpha.com/news/3502736-newlinkminus-1_3-on-lumos-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3502736-newlinkminus-1_3-on-lumos-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502734\" data-ts=\"1569877071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENB\" target=\"_blank\">ENB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502734-enbridge-slides-after-regulators-mainline-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enbridge slides after regulator&#39;s Mainline ruling</a></h4><ul><li>Enbridge (NYSE:<a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a>) tumbled 2.7% in today's U.S. trade after the Canada Energy Regulator <a href=\"https://seekingalpha.com/news/3502459-enbridge-mainline-open-season-stopped-regulator\" target=\"_blank\">stopped the open season </a> it sought for service on its Canadian Mainline oil pipeline system.</li><li>Enbridge says the CER decision announced late Friday <a href=\"https://www.cbc.ca/news/canada/calgary/canada-energy-regulator-enbridge-suspend-open-season-pipeline-shares-1.5302819\" target=\"_blank\">changes the timing</a> but it still intends to proceed with signing  firm contracts with shippers on the system that moves 70% of Canada's crude exports into the U.S.</li><li>Canadian oil producers were mostly opposed to  ENB's attempt to contract the system at this time.</li><li>Analysts rate the decision as slightly negative for ENB since it means the company must now apply to the CER to  approve the tolls, terms and conditions of the proposed service change  before another open season can proceed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502734\" data-linked=\"Enbridge slides after regulator&#39;s Mainline ruling\" data-tweet=\"$ENB - Enbridge slides after regulator&#39;s Mainline ruling https://seekingalpha.com/news/3502734-enbridge-slides-after-regulators-mainline-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3502734-enbridge-slides-after-regulators-mainline-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502725\" data-ts=\"1569875644\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GERN\" target=\"_blank\">GERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502725-geronplus-12_7-on-fast-track-designation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Geron +12.7% on fast-track designation</a></h4><ul><li>Geron (NASDAQ:<a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a>) <a href=\"https://seekingalpha.com/pr/17648131-geron-announces-fast-track-designation-granted-imetelstat-relapsed-refractory-myelofibrosis\" target=\"_blank\">announces</a> the FDA granted fast-track designation to imetelstat for the treatment of adult patients with Intermediate-2 or High-risk myelofibrosis &#40;MF&#41; whose disease has relapsed after or is refractory to janus kinase &#40;JAK&#41; inhibitor treatment, or relapsed/refractory MF.</li><li>The designation includes patients with primary MF and MF developed after essential thrombocythemia.</li><li>The same patient population was studied in the IMbark Phase 2 clinical trial.</li><li>Geron intends to conduct an end of Phase 2 meeting with the FDA by the end of Q1 to see if there's a regulatory path forward for imetelstat in relapsed/refractory MF.</li><li>GERN shares are <font color=\"green\">up 12.7%</font> after hours to $1.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502725\" data-linked=\"Geron +12.7% on fast-track designation\" data-tweet=\"$GERN - Geron +12.7% on fast-track designation https://seekingalpha.com/news/3502725-geronplus-12_7-on-fast-track-designation?source=tweet\" data-url=\"https://seekingalpha.com/news/3502725-geronplus-12_7-on-fast-track-designation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502715\" data-ts=\"1569874997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SENS\" target=\"_blank\">SENS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502715-senseonics-completes-promise-study-enrollment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senseonics completes PROMISE study enrollment</a></h4><ul><li>Senseonics (NYSEMKT:<a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings, Inc.'>SENS</a>) <a href=\"https://seekingalpha.com/pr/17648092-senseonics-announces-completion-us-patient-enrollment-promise-180-day-sensor-clinical-study\" target=\"_blank\">announces</a> completing enrollment in Eversense PROMISE 180-day sensor clinical study, which includes 181 participants across eight U.S. sites.</li><li>The safety and efficacy study focuses on the Eversense CGM System in patients with diabetes for the pre-market application submission to the FDA.</li><li>SENS shares are <font color=\"green\">up 1.85%</font> after hours to $1.01.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502715\" data-linked=\"Senseonics completes PROMISE study enrollment\" data-tweet=\"$SENS - Senseonics completes PROMISE study enrollment https://seekingalpha.com/news/3502715-senseonics-completes-promise-study-enrollment?source=tweet\" data-url=\"https://seekingalpha.com/news/3502715-senseonics-completes-promise-study-enrollment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502757\" data-ts=\"1569873352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLE\" target=\"_blank\">XLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502757-oil-energy-stocks-sink-saudis-restore-output-capacity-to-pre-attack-levels\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil, energy stocks sink as Saudis restore output capacity to pre-attack levels</a></h4><ul><li>Energy (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color=\"red\">-0.7%</font>) is the only S&amp;P sector clearly in the red in today's trade, as <a href=\"https://www.cnbc.com/2019/09/30/oil-markets-us-china-trade-war-in-focus.html\" target=\"_blank\">crude oil tumbles</a> amid another weak economic outlook from China and a top Saudi Aramco official said <a href=\"https://www.reuters.com/article/us-saudi-security-oil-aramco/saudi-aramco-restored-full-oil-capacity-to-pre-attack-level-trading-unit-chief-idUSKBN1WF1T0\" target=\"_blank\">oil capacity had recovered</a> to levels prior to the Sept. 14 drone attack.</li><li>November WTI crude settled <font color=\"red\">-3.3%</font> to $54.07/bbl, while Brent finished <font color=\"red\">-1.9%</font> at $60.75/bbl.</li><li>\"Speculation that production would be back online much quicker than initially thought was the main driver of last week's declines\" and news of fully restored output \"confirmed those expectations, which <a href=\"https://www.marketwatch.com/story/oil-extends-slump-but-remains-on-track-for-a-monthly-gain-2019-09-30\" target=\"_blank\">resulted in continued selling</a>,\" says Tyler Richey of Sevens Report Research.</li><li>Coinciding with the Saudi report, Aramco (<a href='https://seekingalpha.com/symbol/ARMCO' title='Saudi Aramco'>ARMCO</a>) unveils plans to <a href=\"https://finance.yahoo.com/news/saudi-aramco-plans-75-billion-121228751.html\" target=\"_blank\">pay out a total annual dividend of $75B</a> as it builds toward an IPO later this year in which it hopes for a $2T valuation.</li><li>Dividends of $75B would give investors a yield of 3.75% if the company achieves the $2T valuation - a decent payout in a low-interest rate world but still a lower dividend than other Big Oil firms including Shell's 6.22% and Exxon's 4.9%.</li><li>Among today's largest losers in the oil and gas sector: <a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a> <font color=\"red\">-10.7%</font>, <a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color=\"red\">-8.4%</font>, <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color=\"red\">-6.4%</font>, <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color=\"red\">-5.4%</font>, <a href='https://seekingalpha.com/symbol/SD' title='SandRidge Energy, Inc.'>SD</a> <font color=\"red\">-5.1%</font>, <a href='https://seekingalpha.com/symbol/VAL' title='Valaris plc'>VAL</a> <font color=\"red\">-4.5%</font>, <a href='https://seekingalpha.com/symbol/JAG' title='Jagged Peak Energy Inc.'>JAG</a> <font color=\"red\">-4.3%</font>, <a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color=\"red\">-4.3%</font>, <a href='https://seekingalpha.com/symbol/SSL' title='Sasol Limited'>SSL</a> <font color=\"red\">-4.2%</font>, <a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a> <font color=\"red\">-4%</font>, <a href='https://seekingalpha.com/symbol/SMLP' title='Summit Midstream Partners, LP'>SMLP</a> <font color=\"red\">-3.9%</font>, <a href='https://seekingalpha.com/symbol/HLX' title='Helix Energy Solutions Group, Inc.'>HLX</a> <font color=\"red\">-3.8%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color=\"red\">-3.5%</font>, <a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling, Inc.'>DO</a> <font color=\"red\">-3.3%</font>,<a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color=\"red\">-3.1%</font>, <a href='https://seekingalpha.com/symbol/NGS' title='Natural Gas Services Group, Inc.'>NGS</a> <font color=\"red\">-3.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P GSCI Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3x Long Crude Oil ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Trust II - ProShares Ultra Bloomberg Crude Oil'>UCO</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/BNO' title='United States Brent Oil Fund, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity Covington Trust - Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3502757\" data-linked=\"Oil, energy stocks sink as Saudis restore output capacity to pre-attack levels\" data-tweet=\"$XLE $ARMCO $FTSI - Oil, energy stocks sink as Saudis restore output capacity to pre-attack levels https://seekingalpha.com/news/3502757-oil-energy-stocks-sink-saudis-restore-output-capacity-to-pre-attack-levels?source=tweet\" data-url=\"https://seekingalpha.com/news/3502757-oil-energy-stocks-sink-saudis-restore-output-capacity-to-pre-attack-levels\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502694\" data-ts=\"1569872123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLD\" target=\"_blank\">GLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502694-gold-mining-stocks-dragged-down-strength-in-dollar-equities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold, mining stocks dragged down by strength in dollar, equities</a></h4><ul><li>Gold futures (<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a> <font color=\"red\">-1.5%</font>) settle below the $1,500/oz. level for their <a href=\"https://www.marketwatch.com/story/gold-loses-bullish-luster-stumbles-below-psychologically-significant-1500-level-2019-09-30\" target=\"_blank\">lowest finish in two months</a>, as strength in the U.S. dollar and some lift in U.S. stocks and yields pulled demand away from safe-haven plays.</li><li>December Comex gold closed <font color=\"red\">-2.2%</font> to $1,472.90/oz., capping a 3.7% drop for the month, although the yellow metal gained 3.4% during Q3; December silver settled <font color=\"red\">-3.7%</font> to $16.99/oz., also the lowest since early August and capping a 7% drop in September while gaining more than 10% for the quarter.</li><li>\"A strong U.S. dollar is a headwind for gold priced in U.S. dollar, however technical considerations may be more influential on today's action in the gold market,\" says Altavest managing partner Michael Armbruster. \"Gold has formed a bearish head-and-shoulders pattern, and today's drop below the formation\u2019s 'neckline' has likely spurred additional selling.\"</li><li>Shares of precious metals miners trade broadly lower: <a href='https://seekingalpha.com/symbol/AXU' title='Alexco Resource Corp.'>AXU</a> <font color=\"red\">-10%</font>, <a href='https://seekingalpha.com/symbol/SVM' title='Silvercorp Metals Inc.'>SVM</a> <font color=\"red\">-9.6%</font>, <a href='https://seekingalpha.com/symbol/SILV' title='SilverCrest Metals Inc.'>SILV</a> <font color=\"red\">-9.4%</font>, <a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Company'>HL</a> <font color=\"red\">-8.7%,</font> <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color=\"red\">-8.7%</font>, <a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a> <font color=\"red\">-8.2%</font>, <a href='https://seekingalpha.com/symbol/USAS' title='Americas Gold and Silver Corporation'>USAS</a> <font color=\"red\">-8%</font>, <a href='https://seekingalpha.com/symbol/SMTS' title='Sierra Metals Inc.'>SMTS</a> <font color=\"red\">-8.1%</font>, <a href='https://seekingalpha.com/symbol/DRD' title='DRDGOLD Limited'>DRD</a> <font color=\"red\">-7.8%</font>, <a href='https://seekingalpha.com/symbol/GSS' title='Golden Star Resources Ltd.'>GSS</a> <font color=\"red\">-7.7%</font>, <a href='https://seekingalpha.com/symbol/GORO' title='Gold Resource Corporation'>GORO</a> <font color=\"red\">-7.5%</font>, <a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines Inc.'>FSM</a> <font color=\"red\">-6.4%</font>, <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color=\"red\">-6.2%</font>, <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color=\"red\">-6%</font>, <a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a> <font color=\"red\">-6%</font>, <a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc.'>NGD</a> <font color=\"red\">-5.6%</font>, <a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc.'>AGI</a> <font color=\"red\">-5.1%</font>, <a href='https://seekingalpha.com/symbol/MAG' title='MAG Silver Corp.'>MAG</a> <font color=\"red\">-5%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color=\"red\">-4.6%</font>, <a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc.'>PVG</a> <font color=\"red\">-4.5%</font>, <a href='https://seekingalpha.com/symbol/SA' title='Seabridge Gold Inc.'>SA</a> <font color=\"red\">-4.2%</font>, <a href='https://seekingalpha.com/symbol/OR' title='Osisko Gold Royalties Ltd'>OR</a> <font color=\"red\">-4.1%</font>, <a href='https://seekingalpha.com/symbol/NG' title='NovaGold Resources Inc.'>NG</a> <font color=\"red\">-3.6%</font>, <a href='https://seekingalpha.com/symbol/SSRM' title='SSR Mining Inc.'>SSRM</a> <font color=\"red\">-3.5%,</font> <a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color=\"red\">-3.3%</font>, <a href='https://seekingalpha.com/symbol/SAND' title='Sandstorm Gold Ltd.'>SAND</a> <font color=\"red\">-3.2%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color=\"red\">-3.2%</font>, <a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color=\"red\">-3.2%</font>, <a href='https://seekingalpha.com/symbol/PAAS' title='Pan American Silver Corp.'>PAAS</a> <font color=\"red\">-3.1%</font>, <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a> <font color=\"red\">-3%</font>, <a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color=\"red\">-2.9%</font>, <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color=\"red\">-2.9%</font>, <a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color=\"red\">-2%</font>, <a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp.'>WPM</a> <font color=\"red\">-1.8%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a>, <a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/SIL' title='Global X Silver Miners ETF'>SIL</a>, <a href='https://seekingalpha.com/symbol/USLV' title='VelocityShares 3x Long Silver ETN'>USLV</a>, <a href='https://seekingalpha.com/symbol/AGQ' title='ProShares Ultra Silver ETF'>AGQ</a>, <a href='https://seekingalpha.com/symbol/JDST' title='Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF'>JDST</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3502694\" data-linked=\"Gold, mining stocks dragged down by strength in dollar, equities\" data-tweet=\"$GLD $AXU $SVM - Gold, mining stocks dragged down by strength in dollar, equities https://seekingalpha.com/news/3502694-gold-mining-stocks-dragged-down-strength-in-dollar-equities?source=tweet\" data-url=\"https://seekingalpha.com/news/3502694-gold-mining-stocks-dragged-down-strength-in-dollar-equities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502687\" data-ts=\"1569870312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502687-fsly-gtt-and-usat-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FSLY, GTT and USAT among tech movers</a></h4><ul><li><strong>Gainers:</strong> USA Technologies (<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>OTC:USAT</a>) <font color=\"green\">+28%</font>. GTT Communications (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) <font color=\"green\">+19%</font>. Aehr Test Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a>) <font color=\"green\">+15%</font>. BroadVision (NASDAQ:<a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a>) <font color=\"green\">+13%</font>. Fastly (NYSE:<a href='https://seekingalpha.com/symbol/FSLY' title='Fastly, Inc.'>FSLY</a>) <font color=\"green\">+9%</font>.</li> <li><strong>Losers:</strong> SCWorx (NASDAQ:<a href='https://seekingalpha.com/symbol/WORX' title='SCWorx Corp.'>WORX</a>) <font color=\"red\">-15%</font>. TuanChe (NASDAQ:<a href='https://seekingalpha.com/symbol/TC' title='TuanChe Limited'>TC</a>) <font color=\"red\">-13%</font>. Pintec Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"red\">-12%</font>. Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings, Inc.'>AWSM</a>) <font color=\"red\">-10%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware, Inc.'>PHUN</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502687\" data-linked=\"FSLY, GTT and USAT among tech movers\" data-tweet=\"$USAT $GTT $AEHR - FSLY, GTT and USAT among tech movers https://seekingalpha.com/news/3502687-fsly-gtt-and-usat-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3502687-fsly-gtt-and-usat-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502686\" data-ts=\"1569870261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502686-deutsche-bank-sees-shake-shack-upside-already-priced-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank sees Shake Shack upside already priced in</a></h4><ul> <li>Deutsche Bank starts off coverage on Shake Shack (<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack Inc.'>SHAK</a> <font color='green'>+2.7%</font>) with a Hold rating.</li><li>\"While we view the long-term growth story as both compelling and legitimate, with shares ~+115% YTD, we can't help but come to the conclusion that the market is pricing in a lot of the aforementioned positive factors at this point in time,\" warns the DB analyst team.</li> <li>The firm assigns a price target of $90 vs. the 52-week trading range of $40.67 to $105.84 and average sell-side PT of <a href=\"https://seekingalpha.com/symbol/SHAK/ratings/sell-side-ratings\" target=\"_blank\">$82.85</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3502686\" data-linked=\"Deutsche Bank sees Shake Shack upside already priced in\" data-tweet=\"$SHAK - Deutsche Bank sees Shake Shack upside already priced in https://seekingalpha.com/news/3502686-deutsche-bank-sees-shake-shack-upside-already-priced-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3502686-deutsche-bank-sees-shake-shack-upside-already-priced-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502673\" data-ts=\"1569866518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502673-contango-oil-gas-and-taronis-technologies-among-energy-materials-gainers-alexco-resource-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Contango Oil &amp; Gas and Taronis Technologies among Energy/Materials gainers; Alexco Resource and Gulfport Energy among losers</a></h4><ul><li><b>Gainers: </b>Contango Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"green\">+16%</font>. Taronis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TRNX' title='Taronis Technologies, Inc.'>TRNX</a>) <font color=\"green\">+8%</font>. Oil States International (NYSE:<a href='https://seekingalpha.com/symbol/OIS' title='Oil States International, Inc.'>OIS</a>) <font color=\"green\">+5%</font>. Avantor (NYSE:<a href='https://seekingalpha.com/symbol/AVTR' title='Avantor, Inc.'>AVTR</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Alexco Resource (NYSEMKT:<a href='https://seekingalpha.com/symbol/AXU' title='Alexco Resource Corp.'>AXU</a>) <font color=\"red\">-12%</font>. Gulfport Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a>) <font color=\"red\">-10%</font>. Antero Resources (NYSE:<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a>) <font color=\"red\">-10%</font>. Hecla Mining (NYSE:<a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Company'>HL</a>) <font color=\"red\">-9%</font>. SilverCrest Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/SILV' title='SilverCrest Metals Inc.'>SILV</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502673\" data-linked=\"Contango Oil &amp; Gas and Taronis Technologies among Energy/Materials gainers; Alexco Resource and Gulfport Energy among losers\" data-tweet=\"$MCF $TRNX $OIS - Contango Oil &amp; Gas and Taronis Technologies among Energy/Materials gainers; Alexco Resource and Gulfport Energy among losers https://seekingalpha.com/news/3502673-contango-oil-gas-and-taronis-technologies-among-energy-materials-gainers-alexco-resource-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3502673-contango-oil-gas-and-taronis-technologies-among-energy-materials-gainers-alexco-resource-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502671\" data-ts=\"1569866136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502671-bristol-myers-higher-after-opdivo-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers higher after Opdivo update</a></h4><ul> <li>Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='green'>+1.8%</font>) is out with results from a Phase 3 Attraction trial of Opdivo for patients with esophageal cancer.</li><li>The company says Opdivo demonstrated a 23% reduction in the risk of death and 2.5-month improvement in median overall survival compared to chemotherapy</li> <li>BMY management is updating on the results at a Presidential Symposium during the European Society for Medical Oncology 2019 Annual Congress.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17647729-opdivo-nivolumab-demonstrates-statistically-significant-overall-survival-benefit-versus\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3502671\" data-linked=\"Bristol-Myers higher after Opdivo update\" data-tweet=\"$BMY - Bristol-Myers higher after Opdivo update https://seekingalpha.com/news/3502671-bristol-myers-higher-after-opdivo-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3502671-bristol-myers-higher-after-opdivo-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502761\" data-ts=\"1569865850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TALO\" target=\"_blank\">TALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502761-pemex-seeks-control-of-talos-energys-billion-barrel-oil-find-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pemex seeks control of Talos Energy&#39;s billion-barrel oil find - Reuters</a></h4><ul><li>Mexico's state-run Pemex oil company <a href=\"https://www.reuters.com/article/us-mexico-oil-zama-exclusive/exclusive-mexicos-pemex-seeks-control-of-u-s-oil-firms-billion-barrel-find-idUSKBN1WF11Z\" target=\"_blank\">wants to take over</a> Talos Energy's (<a href='https://seekingalpha.com/symbol/TALO' title='Talos Energy Inc.'>TALO</a> <font color='red'>-4.2%</font>) Zama offshore oilfield, Reuters reports, citing two former Mexican energy officials and two company executives with knowledge of internal Pemex discussions.</li><li>If Pemex takes over, Talos would retain its 35% stake but give up operational control, according to the report, undermining its attempt to establish itself as an international operator with its first project outside the U.S.</li><li>Talos also would be forced to rely on Pemex to execute drilling efficiently and profitably - no sure bet given that Pemex is the world's most indebted oil firm and has seen its production decline by half since 2004 as it struggled with aging fields and underinvestment.</li><li>Pemex likely has a claim to about a third of the oil in the deposit that extends into the Zama field, according to consultants at Wood Mackenzie, but the company's efforts to prove its share by drilling have been delayed \"multiple times,\" while the Talos-led consortium has drilled four wells and spent $250M.</li><li>The two companies have until September 2020 to conclude a negotiation over a merged project; under Talos' current contract, the Mexican government would get nearly 70% of net profits from Zama.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502761\" data-linked=\"Pemex seeks control of Talos Energy&#39;s billion-barrel oil find - Reuters\" data-tweet=\"$TALO - Pemex seeks control of Talos Energy&#39;s billion-barrel oil find - Reuters https://seekingalpha.com/news/3502761-pemex-seeks-control-of-talos-energys-billion-barrel-oil-find-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3502761-pemex-seeks-control-of-talos-energys-billion-barrel-oil-find-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502660\" data-ts=\"1569862908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502660-patrick-industries-leads-industrial-gainers-cemtrex-and-astrotech-in-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Patrick Industries leads industrial gainers; Cemtrex and Astrotech in losers</a></h4><ul><li><b>Gainers: </b>Patrick Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/PATK' title='Patrick Industries, Inc.'>PATK</a>) <font color=\"green\">+11%</font>. The Dixie Group (NASDAQ:<a href='https://seekingalpha.com/symbol/DXYN' title='The Dixie Group, Inc.'>DXYN</a>) <font color=\"green\">+8%</font>. Perma-Fix Environmental Services (NASDAQ:<a href='https://seekingalpha.com/symbol/PESI' title='Perma-Fix Environmental Services, Inc.'>PESI</a>) <font color=\"green\">+6%</font>. Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"green\">+5%</font>. KB Home (NYSE:<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"red\">-6%</font>. Astrotech (NASDAQ:<a href='https://seekingalpha.com/symbol/ASTC' title='Astrotech Corporation'>ASTC</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502660\" data-linked=\"Patrick Industries leads industrial gainers; Cemtrex and Astrotech in losers\" data-tweet=\"$PATK $DXYN $PESI - Patrick Industries leads industrial gainers; Cemtrex and Astrotech in losers https://seekingalpha.com/news/3502660-patrick-industries-leads-industrial-gainers-cemtrex-and-astrotech-in-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3502660-patrick-industries-leads-industrial-gainers-cemtrex-and-astrotech-in-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502662\" data-ts=\"1569862869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502662-palomar-holdings-and-cohen-company-only-financial-gainers-atlanticus-holdings-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palomar Holdings and Cohen &amp; Company the only financial gainers, Atlanticus Holdings leads losers</a></h4><ul><li><b>Gainers:</b> Palomar Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PLMR' title='Palomar Holdings, Inc.'>PLMR</a>) <font color=\"green\">+9%</font>. Cohen &amp; Company (NYSEMKT:<a href='https://seekingalpha.com/symbol/COHN' title='Cohen & Company Inc.'>COHN</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers:</b> Atlanticus Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ATLC' title='Atlanticus Holdings Corporation'>ATLC</a>) <font color=\"red\">-11%</font>. Elbit Imaging (<a href='https://seekingalpha.com/symbol/EMITF' title='Elbit Imaging Ltd.'>OTC:EMITF</a>) <font color=\"red\">-7%</font>. Realogy Holdings (NYSE:<a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings Corp.'>RLGY</a>) <font color=\"red\">-6%</font>. LendingClub (NYSE:<a href='https://seekingalpha.com/symbol/LC' title='LendingClub Corporation'>LC</a>) <font color=\"red\">-5%</font>. Victory Capital Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VCTR' title='Victory Capital Holdings, Inc.'>VCTR</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502662\" data-linked=\"Palomar Holdings and Cohen &amp; Company the only financial gainers, Atlanticus Holdings leads losers\" data-tweet=\"$PLMR $COHN $ATLC - Palomar Holdings and Cohen &amp; Company the only financial gainers, Atlanticus Holdings leads losers https://seekingalpha.com/news/3502662-palomar-holdings-and-cohen-company-only-financial-gainers-atlanticus-holdings-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3502662-palomar-holdings-and-cohen-company-only-financial-gainers-atlanticus-holdings-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502661\" data-ts=\"1569862678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502661-thor-results-lift-rv-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thor results lift RV sector</a></h4><ul> <li>The RV sector is rallying after Thor Industries (<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color=\"green\">+20.1%</font>) struck a very confident in setting its outlook for FY20 amid weakened sentiment on the industry.</li> <li>Gainers include Camping World Holdings (<a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings, Inc.'>CWH</a> <font color=\"green\">+4.2%</font>), Winnebago (<a href='https://seekingalpha.com/symbol/WGO' title='Winnebago Industries, Inc.'>WGO</a> <font color=\"green\">+7%</font>), Patrick Industries (<a href='https://seekingalpha.com/symbol/PATK' title='Patrick Industries, Inc.'>PATK</a> <font color=\"green\">+10.7%</font>) and LCI Industries (<a href='https://seekingalpha.com/symbol/LCII' title='LCI Industries'>LCII</a> <font color=\"green\">+4.2%</font>). Specialty vehicles maker REV Group (<a href='https://seekingalpha.com/symbol/REVG' title='REV Group, Inc.'>REVG</a> <font color='green'>+5.4%</font>) is also having a solid day.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3502661\" data-linked=\"Thor results lift RV sector\" data-tweet=\"$THO $CWH $WGO - Thor results lift RV sector https://seekingalpha.com/news/3502661-thor-results-lift-rv-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3502661-thor-results-lift-rv-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502659\" data-ts=\"1569862047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SXC\" target=\"_blank\">SXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502659-suncoke-energy-cut-b-riley-fbr-amid-several-headline-risks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunCoke Energy cut at B. Riley FBR amid several headline risks</a></h4><ul><li>SunCoke Energy (<a href='https://seekingalpha.com/symbol/SXC' title='SunCoke Energy, Inc.'>SXC</a> <font color='red'>-7.6%</font>) slumps to a 52-week low after B. Riley FBR <a href=\"https://thefly.com/thestreet/realmoney/index.php/SXCid2969435/SXC-B-Riley-FBR-downgrades-SunCoke-Energy-to-Neutral-on-headline-risks\" target=\"_blank\">downgrades</a> shares to Neutral from Buy with an $8 price target, cut from $12, as the firm sees a number of events that present \"significant headline risk\" for the stock and a lack of near-term positive catalysts.</li><li>The terms at which SXC will renegotiate its contracts with two key customers expiring over the next two years is unclear, says Riley analyst Lucas Pipes.</li><li>SXC has significant counterparty risk at the Convent Marine Terminal, as its two customers potentially could enter a near-term restructuring process, Pipes says; if this happens, the status of SXC's take-or-pay contracts with one or both companies likely would be scrutinized in a bankruptcy proceeding.</li><li>Pipes also says it remains unclear how SXC management plans to allocate capital regarding its stated intentions to grow via organic investment or acquisition.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502659\" data-linked=\"SunCoke Energy cut at B. Riley FBR amid several headline risks\" data-tweet=\"$SXC - SunCoke Energy cut at B. Riley FBR amid several headline risks https://seekingalpha.com/news/3502659-suncoke-energy-cut-b-riley-fbr-amid-several-headline-risks?source=tweet\" data-url=\"https://seekingalpha.com/news/3502659-suncoke-energy-cut-b-riley-fbr-amid-several-headline-risks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502656\" data-ts=\"1569861282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502656-gthx-patk-sgen-and-tho-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GTHX, PATK. SGEN and THO among midday movers</a></h4><ul><li><strong>Gainers: </strong>Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) <font color=\"green\">+38%</font>. USA Technologies (<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>OTC:USAT</a>) <font color=\"green\">+28%</font>. Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi, Inc.'>FAMI</a>) <font color=\"green\">+24%</font>. Thor Industries (NYSE:<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a>) <font color=\"green\">+21%</font>. GTT Communications (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) <font color=\"green\">+15%</font>. Patrick Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/PATK' title='Patrick Industries, Inc.'>PATK</a>) <font color=\"green\">+12%</font>. Seattle Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a>) <font color=\"green\">+10%</font>. Stealth BioTherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MITO' title='Stealth BioTherapeutics Corp'>MITO</a>) <font color=\"green\">+10%</font>. BroadVision (NASDAQ:<a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a>) <font color=\"green\">+10%</font>. Aehr Test Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>Adamas Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMS' title='Adamas Pharmaceuticals, Inc.'>ADMS</a>) <font color=\"red\">-25%</font>. G1 Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics, Inc.'>GTHX</a>) <font color=\"red\">-25%</font>. BioCardia (<a href='https://seekingalpha.com/symbol/BCDA' title='BioCardia, Inc.'>OTCQB:BCDA</a>) <font color=\"red\">-18%</font>. NanoViricides (NYSEMKT:<a href='https://seekingalpha.com/symbol/NNVC' title='NanoViricides, Inc.'>NNVC</a>) <font color=\"red\">-16%</font>. Calithera Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences, Inc.'>CALA</a>) <font color=\"red\">-16%</font>. Arcus Biosciences (NYSE:<a href='https://seekingalpha.com/symbol/RCUS' title='Arcus Biosciences, Inc.'>RCUS</a>) <font color=\"red\">-15%</font>. Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) <font color=\"red\">-15%</font>. DURECT Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DRRX' title='DURECT Corporation'>DRRX</a>) <font color=\"red\">-14%</font>. Globus Maritime Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Limited'>GLBS</a>) <font color=\"red\">-14%</font>. Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a>) <font color=\"red\">-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502656\" data-linked=\"GTHX, PATK. SGEN and THO among midday movers\" data-tweet=\"$DOVA $USAT $FAMI - GTHX, PATK. SGEN and THO among midday movers https://seekingalpha.com/news/3502656-gthx-patk-sgen-and-tho-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3502656-gthx-patk-sgen-and-tho-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502654\" data-ts=\"1569861029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGEN\" target=\"_blank\">SGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502654-seattle-genetics-surges-on-bladder-cancer-treatment-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seattle Genetics surges on bladder cancer treatment results</a></h4><ul><li>Seattle Genetics (<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a> <font color='green'>+10.2%</font>) breaks out to an all-time high after the company and partner Astellas Pharma (<a href='https://seekingalpha.com/symbol/ALPMY' title='Astellas Pharma Inc.'>OTCPK:ALPMY</a>) presented <a href=\"https://seekingalpha.com/pr/17646791-seattle-genetics-astellas-announce-results-phase-1-trial-investigational-agent-enfortumab\" target=\"_blank\">\"encouraging\" initial results</a> for a bladder cancer treatment.</li><li>SGEN says 45 patients were evaluated for safety with the combination of its enfortumab vedotin experimental drug and the pembrolizumab immune therapy in previously untreated patients with locally advanced or metastatic urothelial cancer who were ineligible for chemotherapy, and the combination showed encouraging clinical activity in a first-line setting.</li><li>The data showed the combination shrank tumors in a majority of patients, resulting in a 71% confirmed objective response rate, and 58% of patients had a partial response.</li><li>\"While exact durability of this combination still needs to be seen, we view the data as <a href=\"https://www.investors.com/news/technology/seattle-genetics-stock-breaks-out-bullishly-bladder-cancer-treatment-results/\" target=\"_blank\">highly impressive</a> in a high unmet need,\" says RBC Capital analyst Kennen MacKay, who rates the SGEN shares at Outperform.</li><li>Immunomedics (<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='red'>-11.3%</font>), which is working on a rival to enfortumab vedotin, is sharply lower on the news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502654\" data-linked=\"Seattle Genetics surges on bladder cancer treatment results\" data-tweet=\"$SGEN $ALPMY $IMMU - Seattle Genetics surges on bladder cancer treatment results https://seekingalpha.com/news/3502654-seattle-genetics-surges-on-bladder-cancer-treatment-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3502654-seattle-genetics-surges-on-bladder-cancer-treatment-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502646\" data-ts=\"1569859328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502646-thor-industries-leads-consumer-gainers-nio-and-cal-maine-foods-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thor Industries leads consumer gainers; NIO and Cal-Maine Foods among losers</a></h4><ul><li><b>Gainers: </b>Thor Industries (NYSE:<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a>) <font color=\"green\">+21%</font>. Natuzzi (NYSE:<a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a>) <font color=\"green\">+19%</font>. Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi, Inc.'>FAMI</a>) <font color=\"green\">+10%</font>. DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDsTEA Inc.'>DTEA</a>) <font color=\"green\">+7%</font>. Newell Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Cal-Maine Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/CALM' title='Cal-Maine Foods, Inc.'>CALM</a>) <font color=\"red\">-11%</font>. NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"red\">-10%</font>. Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"red\">-7%</font>. Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502646\" data-linked=\"Thor Industries leads consumer gainers; NIO and Cal-Maine Foods among losers\" data-tweet=\"$THO $NTZ $FAMI - Thor Industries leads consumer gainers; NIO and Cal-Maine Foods among losers https://seekingalpha.com/news/3502646-thor-industries-leads-consumer-gainers-nio-and-cal-maine-foods-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3502646-thor-industries-leads-consumer-gainers-nio-and-cal-maine-foods-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502645\" data-ts=\"1569859005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGLD\" target=\"_blank\">RGLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502645-royal-gold-names-cfo-heissenbuttel-new-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Royal Gold names CFO Heissenbuttel as new CEO</a></h4><ul><li>Royal Gold (<a href='https://seekingalpha.com/symbol/RGLD' title='Royal Gold, Inc.'>RGLD</a> <font color=\"red\">-1.7%</font>) appoints William Heissenbuttel as its <a href=\"https://seekingalpha.com/pr/17647731-william-heissenbuttel-appointed-president-chief-executive-officer-royal-gold-effective\" target=\"_blank\">new President and CEO</a>, to become effective upon the retirement of Tony Jensen on Jan. 2, 2020.</li><li>Heissenbuttel joined RGLD in 2006, became VP of operations during 2015-16 and has served as CFO and VP of strategy since June 2018; previously he was Senior VP at N.M. Rothschild and was responsible for the natural resources sector lending team for the Americas.</li><li>Jensen has spent 16 years at RGLD, including 13 as President and CEO, following 18 years at Placer Dome.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502645\" data-linked=\"Royal Gold names CFO Heissenbuttel as new CEO\" data-tweet=\"$RGLD - Royal Gold names CFO Heissenbuttel as new CEO https://seekingalpha.com/news/3502645-royal-gold-names-cfo-heissenbuttel-new-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3502645-royal-gold-names-cfo-heissenbuttel-new-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502631\" data-ts=\"1569856748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502631-apples-mini-led-switch-benefits-lg-says-analyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple&#39;s mini LED switch benefits LG, says analyst</a></h4><ul><li>Noted Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) analyst Ming-Chi Kuo says the company will start using mini LED screens in MacBooks and iPads as early as Q4 CY20 to H1 2021.</li><li>The mini LEDs offer some OLED benefits but aren't as susceptible to \"burn in\" problems and would help Apple cut its supplier reliance on Samsung (<a href='https://seekingalpha.com/symbol/SSNNF' title='Samsung Electronics Co., Ltd.'>OTC:SSNNF</a>,<a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>).</li><li>Kuo names LG Display (<a href='https://seekingalpha.com/symbol/LPL' title='LG Display Co., Ltd.'>LPL</a> <font color='green'>+3.5%</font>) as one of the main beneficiaries of Apple's screen switch.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502631\" data-linked=\"Apple&#39;s mini LED switch benefits LG, says analyst\" data-tweet=\"$AAPL $SSNNF $SSNLF - Apple&#39;s mini LED switch benefits LG, says analyst https://seekingalpha.com/news/3502631-apples-mini-led-switch-benefits-lg-says-analyst?source=tweet\" data-url=\"https://seekingalpha.com/news/3502631-apples-mini-led-switch-benefits-lg-says-analyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502630\" data-ts=\"1569856636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502630-lexicon-pharmaminus-13_8-mako-warns-of-deal-breakup-disaster\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon Pharma -13.8% as Mako warns of deal breakup &#39;disaster&#39;</a></h4><ul>   <li>Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) is now <font color=\"red\">off 13.8%</font> today on heavy volume following a <a href=\"https://seekingalpha.com/article/4293926-sanofi-lobs-huge-liability-back-lexicon-pharma-deal-breakup-lexicon-now-options-nearly-cash\" target=\"_blank\">very bearish take</a> from Seeking Alpha contributor Mako Research.</li>    <li>A breakup of the company's deal with Sanofi for develping sotaglifozin will throw responsibility for late-stage trials to Lexicon, accelerating cash burn, Mako says -- and the company admits it doesn't have enough cash to finish the ongoing trials, \"much less fund a commercial launch.\"</li>    <li>\"On closer examination it\u2019s clear that the terms of the termination are a disaster for Lexicon and its investors,\" Mako says.</li>    <li>Sell-side analysts rate the stock <a href=\"https://seekingalpha.com/symbol/LXRX/ratings/sell-side-ratings\" target=\"_blank\">Outperform on average</a>, while <a href=\"https://seekingalpha.com/symbol/LXRX/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Neutral overall</a>. The stock has a <a href=\"https://seekingalpha.com/symbol/LXRX/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Very Bearish</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3502630\" data-linked=\"Lexicon Pharma -13.8% as Mako warns of deal breakup &#39;disaster&#39;\" data-tweet=\"$LXRX - Lexicon Pharma -13.8% as Mako warns of deal breakup &#39;disaster&#39; https://seekingalpha.com/news/3502630-lexicon-pharmaminus-13_8-mako-warns-of-deal-breakup-disaster?source=tweet\" data-url=\"https://seekingalpha.com/news/3502630-lexicon-pharmaminus-13_8-mako-warns-of-deal-breakup-disaster\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502625\" data-ts=\"1569855894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502625-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) <font color=\"green\">+39%</font>. Stealth BioTherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MITO' title='Stealth BioTherapeutics Corp'>MITO</a>) <font color=\"green\">+15%</font>. TrovaGene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) <font color=\"green\">+14%</font>. Seattle Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a>) <font color=\"green\">+13%</font>. LogicBio Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGC' title='LogicBio Therapeutics, Inc.'>LOGC</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>G1 Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics, Inc.'>GTHX</a>) <font color=\"red\">-23%</font>. Adamas Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMS' title='Adamas Pharmaceuticals, Inc.'>ADMS</a>) <font color=\"red\">-21%</font>. Calithera Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences, Inc.'>CALA</a>) <font color=\"red\">-18%</font>. Arcus Biosciences (NYSE:<a href='https://seekingalpha.com/symbol/RCUS' title='Arcus Biosciences, Inc.'>RCUS</a>) <font color=\"red\">-14%</font>. Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) <font color=\"red\">-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502625\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$DOVA $MITO $TROV - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3502625-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3502625-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502627\" data-ts=\"1569855591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSGN\" target=\"_blank\">MSGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502627-msg-networksplus-2_2-amid-results-of-share-tender\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MSG Networks +2.2% amid results of share tender</a></h4><ul>   <li>MSG Networks (<a href=\"http://seekingalpha.com/symbol/MSGN\" target=\"_blank\">MSGN</a> <font color=\"green\">+2.2%</font>) says in preliminary results that <a href=\"https://seekingalpha.com/pr/17647081-msg-networks-announces-preliminary-results-modified-dutch-auction-tender-offer\" target=\"_blank\">just under 15M share</a>s have been tendered in its modified Dutch auction.</li>    <li>The company <a href=\"https://seekingalpha.com/news/3495849-msg-networks-plus-3_4-percent-bigger-buyback-share-tender\" target=\"_blank\">launched the tender</a> (to buy up to $250M in class A common stock) a month ago.</li>    <li>The 14,980,092 shares were tendered at or below the purchase price of $16.70/share, and MSG Networks expects to accept those for purchase for an aggregate cost of $250.17M. Shares are up to $16.68.</li>    <li>Those share make up about 24.3% of outstanding class A shares.</li>    <li>The company will pay using cash on hand and borrowings under its revolving credit facility.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502627\" data-linked=\"MSG Networks +2.2% amid results of share tender\" data-tweet=\"$MSGN - MSG Networks +2.2% amid results of share tender https://seekingalpha.com/news/3502627-msg-networksplus-2_2-amid-results-of-share-tender?source=tweet\" data-url=\"https://seekingalpha.com/news/3502627-msg-networksplus-2_2-amid-results-of-share-tender\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502622\" data-ts=\"1569854849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VAL\" target=\"_blank\">VAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502622-valaris-wins-rig-deal-for-neptune-energy-s-seagull-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valaris wins rig deal for Neptune Energy;s Seagull project</a></h4><ul><li>Valaris (<a href='https://seekingalpha.com/symbol/VAL' title='Valaris plc'>VAL</a> <font color='red'>-4.4%</font>) says it was <a href=\"https://www.offshoreenergytoday.com/valaris-rig-hired-for-neptunes-seagull-project/\" target=\"_blank\">awarded a contract</a> by Neptune Energy to provide a heavy-duty jack-up drilling rig for the Seagull development oil project in the U.K. North Sea; financial terms are not disclosed.</li><li>Neptune says VAL's <em>Rowan Gorilla VI</em> will drill four  firm wells for the development in an 18-month drilling campaign scheduled to  start in Q3 2020.</li><li>Neptune is the operator of Seagull and holds a 35% interest, but <a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> actually owns a 50% stake in the project while JAPEX has 15%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502622\" data-linked=\"Valaris wins rig deal for Neptune Energy;s Seagull project\" data-tweet=\"$VAL $BP - Valaris wins rig deal for Neptune Energy;s Seagull project https://seekingalpha.com/news/3502622-valaris-wins-rig-deal-for-neptune-energy-s-seagull-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3502622-valaris-wins-rig-deal-for-neptune-energy-s-seagull-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502617\" data-ts=\"1569854397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGNA\" target=\"_blank\">TGNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502617-tegna-holder-standard-general-takes-active-stance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tegna holder Standard General takes more active stance</a></h4><ul>   <li>Tegna (NYSE:<a href='https://seekingalpha.com/symbol/TGNA' title='TEGNA Inc.'>TGNA</a>) shareholder Standard General has switched its <a href=\"https://seekingalpha.com/filing/4649561\" target=\"_blank\">SEC ownership disclosure</a> to a 13D from a 13G, pointing to a more active stance on its investment.</li>    <li>Since filing its 13G on Aug. 14, Standard General has \"observed news articles, disclosures by the Issuer, and third party research reports regarding possible M&amp;A activity relating to the Issuer.\"</li>    <li>Pointing to experience as shareholders and directors of TV broadcasters and a \"successful track record of overseeing acquisitions, mergers and sales processes\" of those companies, Standard General now intends to become actively engaged with Tegna.</li>    <li>\"These activities may include speaking with management, the board, other shareholders, and third parties to gather information and share the Reporting Persons\u2019 views on the Issuer\u2019s strategic alternatives, including the previously disclosed offers for the Issuer as well any other proposals that may be made to the Issuer.\"</li>    <li>Tegna shares are <font color=\"green\">up 3.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502617\" data-linked=\"Tegna holder Standard General takes more active stance\" data-tweet=\"$TGNA - Tegna holder Standard General takes more active stance https://seekingalpha.com/news/3502617-tegna-holder-standard-general-takes-active-stance?source=tweet\" data-url=\"https://seekingalpha.com/news/3502617-tegna-holder-standard-general-takes-active-stance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502607\" data-ts=\"1569852204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UXIN\" target=\"_blank\">UXIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502607-uxin-enters-definitive-divestiture-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uxin enters definitive divestiture agreement</a></h4><ul><li>Uxin (<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a> <font color='red'>-1.6%</font>) <a href=\"https://seekingalpha.com/pr/17647149-uxin-announces-entry-definitive-agreements-golden-pacer\" target=\"_blank\">enters</a> into a definitive agreement with Golden Pacer to divest its loan facilitation-related business. The deal is expected to close by the end of 2019.</li><li>UXIN <a href=\"https://seekingalpha.com/news/3477406-uxin-divest-loan-facilitation-related-business-golden-pacer-shares-10-percent-premarket\" target=\"_blank\">announced in July</a> that it had entered a binding term sheet with Golden Pacer related to the divestiture.</li><li>The company will receive $100M in cash and certain preferred shares of Golden Pacer, representing about 18.4% of Golden Pacer's share capital.</li><li>Uxin will also have the right to appoint one director to Golden Pacer's board.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502607\" data-linked=\"Uxin enters definitive divestiture agreement\" data-tweet=\"$UXIN - Uxin enters definitive divestiture agreement https://seekingalpha.com/news/3502607-uxin-enters-definitive-divestiture-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3502607-uxin-enters-definitive-divestiture-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502605\" data-ts=\"1569851875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502605-new-media-gannett-set-meetings-to-approve-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Media, Gannett set meetings to approve merger</a></h4><ul>    <li>New Media Investment Group (<a href=\"http://seekingalpha.com/symbol/NEWM\" target=\"_blank\">NEWM</a> <font color=\"green\">+1.8%</font>) and Gannett (<a href=\"http://seekingalpha.com/symbol/GCI\" target=\"_blank\">GCI</a> <font color=\"green\">+1.4%</font>) have set special meetings for their shareholders to vote on New Media's acquisition of Gannett.</li>    <li>New Media set its meeting for <a href=\"https://seekingalpha.com/pr/17647072-new-media-sets-date-special-meeting-shareholders-vote-merger-agreement-gannett\" target=\"_blank\">8 a.m. ET Nov. 14</a>. Sept. 26 was the record date for the special meeting, the same day that the Hart-Scott-Rodino waiting period on the deal expired.</li>    <li>And Gannett <a href=\"https://seekingalpha.com/pr/17647070-gannett-sets-date-special-meeting-shareholders-vote-merger-agreement-new-media\" target=\"_blank\">set its meeting for 10 a.m. ET</a> on Nov. 14; Sept. 26 was also the record date for that meeting.</li>    <li>Aside from approval by both groups of shareholders, the deal needs clearance from the European Commission. It's expected to close by year-end.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502605\" data-linked=\"New Media, Gannett set meetings to approve merger\" data-tweet=\"$NEWM $GCI - New Media, Gannett set meetings to approve merger https://seekingalpha.com/news/3502605-new-media-gannett-set-meetings-to-approve-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3502605-new-media-gannett-set-meetings-to-approve-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502583\" data-ts=\"1569849539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URBN\" target=\"_blank\">URBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502583-urban-outfittersplus-3-after-wells-fargo-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Urban Outfitters +3% after Wells Fargo boost</a></h4><ul> <li>Wells Fargo lifts Urban Outfitters (NASDAQ:<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a>) to an Outperform rating from Market Perform after taking in management commentary at a consumer conference last week.</li> <li>\"We believe the possibility of positive comps and flattish GMs in 4Q are squarely on the table \u2013 presenting meaningful upside to numbers (and potentially multiple as investors look to 1H20\u2019s very easy setup),\" advises WF.</li> <li>The firm sees URBN capable of executing a turnaround. A new price target is lined up at $30 vs. $25 prior and the average sell-side PT of <a href=\"https://seekingalpha.com/symbol/URBN/ratings/sell-side-ratings\" target=\"_blank\">$27.78</a>.</li> <li>Shares of Urban Outfitters are <font color=\"green\">up 2.67%</font> premarket to $26.90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502583\" data-linked=\"Urban Outfitters +3% after Wells Fargo boost\" data-tweet=\"$URBN - Urban Outfitters +3% after Wells Fargo boost https://seekingalpha.com/news/3502583-urban-outfittersplus-3-after-wells-fargo-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3502583-urban-outfittersplus-3-after-wells-fargo-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502581\" data-ts=\"1569849454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRP\" target=\"_blank\">CTRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502581-ctrip-complus-1_5-gf-securities-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ctrip.com +1.5% as GF Securities starts at Buy</a></h4><ul>   <li>Ctrip.com (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRP' title='Ctrip.com International, Ltd.'>CTRP</a>) is <font color=\"green\">up 1.5%</font> premarket after an initiation at Buy by GF Securities.</li>    <li>The firm set its price target on American depository receipts to $35.30, implying 22% upside.</li>    <li>Sell-side analysts rate it <a href=\"https://seekingalpha.com/symbol/CTRP/ratings/sell-side-ratings\" target=\"_blank\">Outperform on average</a>, and <a href=\"https://seekingalpha.com/symbol/CTRP/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Bullish</a>; the shares have a <a href=\"https://seekingalpha.com/symbol/CTRP/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3502581\" data-linked=\"Ctrip.com +1.5% as GF Securities starts at Buy\" data-tweet=\"$CTRP $TCOM - Ctrip.com +1.5% as GF Securities starts at Buy https://seekingalpha.com/news/3502581-ctrip-complus-1_5-gf-securities-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3502581-ctrip-complus-1_5-gf-securities-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502580\" data-ts=\"1569849396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOVA\" target=\"_blank\">DOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502580-dova-pharma-to-be-acquired-sobi-shares-up-up-38-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dova Pharma to be acquired by Sobi; shares up up 38% premarket</a></h4><ul> <li>Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) is up <font color=\"green\">38%</font> premarket after <a href=\"https://seekingalpha.com/pr/17646927-dova-pharmaceuticals-acquired-swedish-orphan-biovitrum-ab-sobi\" target=\"_blank\">entering</a> into an agreement and plan of merger with Swedish Orphan Biovitrum AB (<a href='https://seekingalpha.com/symbol/BIOVF' title='Swedish Orphan Biovitrum AB &#40;publ&#41;'>OTCPK:BIOVF</a>) (Sobi).</li><li>Under the terms agreement, an indirect subsidiary of Sobi will commence a tender offer for all outstanding shares of Dova, whereby Dova stockholders will be offered an upfront payment for $27.50/share in cash, along with one non-tradeable Contingent Value Right &#40;CVR&#41; that entitles them to an additional $1.50/share in cash upon regulatory approval of DOPTELET for the treatment of chemotherapy-induced thrombocytopenia, representing a total potential consideration of $29.00/share, or up to $915M on a fully diluted basis.</li>     <li>The transaction is expected to close in Q4 2019.</li>        </ul><div class=\"tiny-share-widget\" data-id=\"3502580\" data-linked=\"Dova Pharma to be acquired by Sobi; shares up up 38% premarket\" data-tweet=\"$DOVA $BIOVF - Dova Pharma to be acquired by Sobi; shares up up 38% premarket https://seekingalpha.com/news/3502580-dova-pharma-to-be-acquired-sobi-shares-up-up-38-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3502580-dova-pharma-to-be-acquired-sobi-shares-up-up-38-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502578\" data-ts=\"1569848942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FN\" target=\"_blank\">FN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502578-fabrinetplus-2-northland-turns-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fabrinet +2% as Northland turns bullish</a></h4><ul><li>Northland Capital upgrades Fabrinet (NYSE:<a href='https://seekingalpha.com/symbol/FN' title='Fabrinet'>FN</a>) from Market Perform to Outperform and raises the target from $44 to $57.</li><li>The firm sees signs of near-term strengths in the silicon photonics and InP telecom businesses.</li><li>Fabrinet shares are <font color=\"green\">up 2.2%</font> to $52.74. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/FN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502578\" data-linked=\"Fabrinet +2% as Northland turns bullish\" data-tweet=\"$FN - Fabrinet +2% as Northland turns bullish https://seekingalpha.com/news/3502578-fabrinetplus-2-northland-turns-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3502578-fabrinetplus-2-northland-turns-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502577\" data-ts=\"1569848906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502577-immu-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IMMU among premarket losers</a></h4><ul><li>Immunomedics (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502577\" data-linked=\"IMMU among premarket losers\" data-tweet=\"$IMMU - IMMU among premarket losers https://seekingalpha.com/news/3502577-immu-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3502577-immu-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502576\" data-ts=\"1569848853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502576-bbby-imgn-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BBBY, IMGN among premarket gainers</a></h4><ul><li>Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) <font color=\"green\">+39%</font> on being <a href=\"https://seekingalpha.com/pr/17646938-sobi-acquire-dova-pharmaceuticals-creating-global-growth-platform-haematology\" target=\"_blank\">acquired</a> by Sobi.</li><li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color=\"green\">+7%</font> after <a href=\"https://seekingalpha.com/news/3502535-bed-bath-and-beyond-rallies-wedbush-upgrade\" target=\"_blank\">Wedbush upgrade</a>.</li><li>ImmunoGen (NASDAQ:<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/pr/17646862-immunogen-presents-initial-data-phase-1b-forward-ii-triplet-cohort-evaluating-mirvetuximab\" target=\"_blank\">initial data</a> from phase 1b forward II triplet cohort evaluating mirvetuximab soravtansine in combination with carboplatin and avastin at ESMO.</li><li>Eros International (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) <font color=\"green\">+6%</font>.</li><li>TrovaGene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/pr/17647351-positive-data-trovagene-phase-1b-2-study-onvansertib-featured-oral-presentation-european\" target=\"_blank\">positive data</a> from Trovagene phase 1b/2 study of onvansertib featured in oral presentation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502576\" data-linked=\"BBBY, IMGN among premarket gainers\" data-tweet=\"$DOVA $BBBY $IMGN - BBBY, IMGN among premarket gainers https://seekingalpha.com/news/3502576-bbby-imgn-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3502576-bbby-imgn-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502573\" data-ts=\"1569848586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IIVI\" target=\"_blank\">IIVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502573-ii-viminus-2-northland-hits-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">II-VI -2% as Northland hits sidelines</a></h4><ul><li>Northland Capital downgrades II-VI (NASDAQ:<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a>) from Outperform to Market Perform and cuts the target from $42 to $39.</li><li>The firm cites headwinds for the datacom unit and merger integration challenges.</li><li>IIVI shares are <font color=\"red\">down 2%</font> pre-market to $35.60. The company has a Neutral <a href=\"https://seekingalpha.com/symbol/IIVI/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502573\" data-linked=\"II-VI -2% as Northland hits sidelines\" data-tweet=\"$IIVI - II-VI -2% as Northland hits sidelines https://seekingalpha.com/news/3502573-ii-viminus-2-northland-hits-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3502573-ii-viminus-2-northland-hits-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502568\" data-ts=\"1569848122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGLY\" target=\"_blank\">DGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502568-dglyplus-7-on-cruise-line-contract-extension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DGLY +7% on cruise line contract extension</a></h4><ul><li>Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>) <a href=\"https://seekingalpha.com/pr/17647392-digital-ally-signs-contract-extension-major-cruise-line-company\" target=\"_blank\">extends the contract</a> with an unspecified major cruise line company for the use of the FirstVu HD body cameras and VuVault.com back-office solution.</li><li>Financial terms weren't disclosed.</li><li>DGLY shares are <font color=\"green\">up 7.4%</font> pre-market to $1.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502568\" data-linked=\"DGLY +7% on cruise line contract extension\" data-tweet=\"$DGLY - DGLY +7% on cruise line contract extension https://seekingalpha.com/news/3502568-dglyplus-7-on-cruise-line-contract-extension?source=tweet\" data-url=\"https://seekingalpha.com/news/3502568-dglyplus-7-on-cruise-line-contract-extension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502567\" data-ts=\"1569848054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACST\" target=\"_blank\">ACST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502567-acasti-pharma-updates-on-trilogy-1-and-2-trials-shares-up-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acasti Pharma updates on Trilogy 1 and 2 trials; shares up 4% premarket</a></h4><ul> <li>Acasti Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma Inc.'>ACST</a>) <a href=\"https://seekingalpha.com/pr/17647429-acasti-pharma-announces-additional-phase-3-milestones-reached-remains-track-report-topline\" target=\"_blank\">reports</a> additional milestones reached and provides a business update on its clinical trials.</li>  <li>ACST's TRILOGY Phase 3 trials in patients with severe hypertriglyceridemia continue to progress, and the Company remains on track to report topline TRILOGY 1 and 2 results in December 2019 and January 2020, respectively.</li><li>Both of TRILOGY studies have achieved 100% patient randomization, and nearly 80% of the patients in both studies combined have now completed their 6-month plan.</li><li>Data clean up is approx. 90% complete in TRILOGY 1.</li>          <li>In addition to the preliminary topline data, the Company plans to present the full data set, including results for key secondary and exploratory endpoints of interest such as Non-HDL-C, LDL-C, VLDL, HDL-C and HbA1c at key scientific meetings in 2020.</li><li>Shares are up <font color=\"green\">4%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3502567\" data-linked=\"Acasti Pharma updates on Trilogy 1 and 2 trials; shares up 4% premarket\" data-tweet=\"$ACST - Acasti Pharma updates on Trilogy 1 and 2 trials; shares up 4% premarket https://seekingalpha.com/news/3502567-acasti-pharma-updates-on-trilogy-1-and-2-trials-shares-up-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3502567-acasti-pharma-updates-on-trilogy-1-and-2-trials-shares-up-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502566\" data-ts=\"1569847767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TK\" target=\"_blank\">TK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502566-teekays-yamal-lng-tanker-jv-blocked-u-s-sanctions-on-cosco\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teekay&#39;s Yamal LNG tanker JV blocked by U.S. sanctions on COSCO</a></h4><ul><li>Teekay Group says it is <a href=\"https://seekingalpha.com/pr/17646943-teekay-group-postpone-investor-day-october-2-2019\" target=\"_blank\">postponing its investor day event</a>, scheduled for Oct. 2 in New York, \"to fully focus on avoiding undue disruption to Teekay LNG's business from certain complex issues that have recently emerged.\"</li><li><a href='https://seekingalpha.com/symbol/TK' title='Teekay Corporation'>TK</a> <font color=\"red\">-4%</font>, <a href='https://seekingalpha.com/symbol/TGP' title='Teekay LNG Partners L.P.'>TGP</a> <font color=\"red\">-3.8%</font> pre-market; Teekay Tankers (NYSE:<a href='https://seekingalpha.com/symbol/TNK' title='Teekay Tankers Ltd.'>TNK</a>) and Teekay Offshore Partners (NYSE:<a href='https://seekingalpha.com/symbol/TOO' title='Teekay Offshore Partners L.P.'>TOO</a>) also will be on watch.</li><li>Teekay says <a href=\"https://seekingalpha.com/news/3502353-oil-shipping-rates-skyrocket-u-s-sanctions-shake-crude-trade\" target=\"_blank\">U.S. sanctions</a> on two units of Chinese shipper COSCO for allegedly carrying Iranian crude oil has blocked its 50-50 Yamal LNG joint venture, as its partner China LNG Shipping Ltd. is 50% owned by COSCO.</li><li>The JV owns four on-the-water ARC7 ice-breaking tankers which  carry gas from the massive Yamal LNG production facility in the Russian  Arctic and two ARC7 LNG carrier newbuildings.</li><li>Given the significant size of COSCO Dalian's tanker fleet, the COSCO sanctions  are having a \"pronounced positive impact on spot tanker rates,\" Teekay also notes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502566\" data-linked=\"Teekay&#39;s Yamal LNG tanker JV blocked by U.S. sanctions on COSCO\" data-tweet=\"$TK $TGP $TNK - Teekay&#39;s Yamal LNG tanker JV blocked by U.S. sanctions on COSCO https://seekingalpha.com/news/3502566-teekays-yamal-lng-tanker-jv-blocked-u-s-sanctions-on-cosco?source=tweet\" data-url=\"https://seekingalpha.com/news/3502566-teekays-yamal-lng-tanker-jv-blocked-u-s-sanctions-on-cosco\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>276&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502556\" data-ts=\"1569845515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502556-mallinckrodtplus-13-after-settling-ohio-opioid-cases\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mallinckrodt +13% after settling Ohio opioid cases</a></h4><ul> <li>Mallinckrodt (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a>) races higher in early trading after <a href=\"https://www.marketwatch.com/story/mallinckrodt-to-pay-24-million-to-ohio-counties-as-part-of-opioid-litigation-settlement-2019-09-30\" target=\"_blank\">settling</a> a legal case with two counties in Ohio involving opioid usage.</li> <li>The company will pay $24M in cash, provide $6M in generic products and provide a $500K payment in two years in recognition of the counties' time and expenses.</li> <li>The settlement sees all named Mallinckrodt entities dismissed with prejudice from the lawsuit and stipulates the value of the settlement won't be extrapolated to any other opioid-related claims.</li> <li>Shares of Mallinckrodt are <font color=\"green\">up 12.89%</font> premarket to $2.54.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502556\" data-linked=\"Mallinckrodt +13% after settling Ohio opioid cases\" data-tweet=\"$MNK - Mallinckrodt +13% after settling Ohio opioid cases https://seekingalpha.com/news/3502556-mallinckrodtplus-13-after-settling-ohio-opioid-cases?source=tweet\" data-url=\"https://seekingalpha.com/news/3502556-mallinckrodtplus-13-after-settling-ohio-opioid-cases\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502548\" data-ts=\"1569844697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNY\" target=\"_blank\">SNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502548-sanofi-to-lighten-workforce-in-japan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanofi to lighten workforce in Japan</a></h4><ul> <li>Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) plans to eliminate about <a href=\"https://www.reuters.com/article/sanofi-japan/french-drugmaker-sanofi-to-cut-around-200-jobs-in-japan-source-idUSL3N26L2NA\" target=\"_blank\">200</a> jobs in Japan, sources tell Reuters.</li> <li>The jobs cuts will be spread across sales, regulatory affairs and operations.</li> <li>\"Sanofi Japan plans to implement a voluntary retirement programme in order to adapt to the external environment changes and to transform our business models to continue our growth,\" confirms a Sanofi rep.</li> <li>Shares of Sanofi are <font color=\"red\">down 0.45%</font> premarket to $46.05.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502548\" data-linked=\"Sanofi to lighten workforce in Japan\" data-tweet=\"$SNY - Sanofi to lighten workforce in Japan https://seekingalpha.com/news/3502548-sanofi-to-lighten-workforce-in-japan?source=tweet\" data-url=\"https://seekingalpha.com/news/3502548-sanofi-to-lighten-workforce-in-japan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502545\" data-ts=\"1569844365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BX\" target=\"_blank\">BX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502545-blackstone-to-buy-colony-industrial-for-5_9b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blackstone to buy Colony Industrial for $5.9B</a></h4><ul><li>Blackstone (NYSE:<a href='https://seekingalpha.com/symbol/BX' title='The Blackstone Group Inc.'>BX</a>) <a href=\"https://seekingalpha.com/news/3490174-colony-capital-puts-industrial-portfolio-sale\" target=\"_blank\">will acquire </a>Colony Industrial, the industrial real estate assets and affiliated industrial operating platform of Colony Capital (NYSE:<a href='https://seekingalpha.com/symbol/CLNY' title='Colony Capital, Inc.'>CLNY</a>), for $5.9B, marking Colony's pivot to focus on digital infrastructure, emerging markets, and energy.</li><li>Colony Capital<font color=\"green\"> surges 14%</font> in premarket trading.</li><li>At the same time, the deal builds up Blackstone's holdings of logistics properties that stand to benefit from e-commerce growth.</li><li>The Colony Industrial last-mile industrial portfolio represents the majority of the total transaction and includes 60M square feet of infill, logistics assets across 465 light industrial buildings in 26 U.S. markets.</li><li>The deal also includes Colony's 51% stake in a 4M-square-foot portfolio of bulk distribution assets and the affiliated operating platform that manages the properties of both portfolios.</li><li>Aggregate net sales proceeds to Colony are expected to be more than $1.2B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3490174-colony-capital-puts-industrial-portfolio-sale\" target=\"_blank\">Colony Capital puts industrial portfolio up for sale</a> (Aug. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3502545\" data-linked=\"Blackstone to buy Colony Industrial for $5.9B\" data-tweet=\"$BX $CLNY - Blackstone to buy Colony Industrial for $5.9B https://seekingalpha.com/news/3502545-blackstone-to-buy-colony-industrial-for-5_9b?source=tweet\" data-url=\"https://seekingalpha.com/news/3502545-blackstone-to-buy-colony-industrial-for-5_9b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502544\" data-ts=\"1569844271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDD\" target=\"_blank\">PDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502544-pinduoduo-closes-1b-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinduoduo closes $1B note offering</a></h4><ul><li>Pinduoduo (NASDAQ:<a href='https://seekingalpha.com/symbol/PDD' title='Pinduoduo Inc.'>PDD</a>) <a href=\"https://seekingalpha.com/pr/17646855-pinduoduo-announces-closing-us-1-billion-convertible-senior-notes-offering\" target=\"_blank\">announces</a> closing offering of convertible senior notes due 2024.</li><li>Initial purchasers fully exercised the option to purchase up to an additional $125M in notes.</li><li>PDD shares are <font color=\"green\">up 2.3%</font> pre-market to $32.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502544\" data-linked=\"Pinduoduo closes $1B note offering\" data-tweet=\"$PDD - Pinduoduo closes $1B note offering https://seekingalpha.com/news/3502544-pinduoduo-closes-1b-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3502544-pinduoduo-closes-1b-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502542\" data-ts=\"1569843733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMGN\" target=\"_blank\">AMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502542-amgenminus-2_0-after-early-stage-amg-510-data-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amgen -2.0% after early stage AMG 510 data disappoints</a></h4><ul><li>Amgen (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>) moves <font color=\"red\">down 2.0%</font> in premarket trading after disclosing<a href=\"https://seekingalpha.com/pr/17646786-amgen-announces-new-clinical-data-evaluating-novel-investigational-kras-g12c-inhibitor\" target=\"_blank\"> new data</a> from the ongoing early-stage study evaluating AMG 510 in patients with previously treated KRAS G12C-mutant solid tumors.</li><li>The Phase 1 study enrolled 76 patients with KRAS G12C-mutant solid tumors; data presented at the European Society for Medical Oncology 2019 Congress include a subset of 55 evaluable patients as of the July 2019 cutoff.</li><li>Of 29 with colorectal cancer, 12 patients received target dose of 960 mg once daily and 10 remain on treatment; one patient in dose cohort experienced partial response and 10 had stable disease for a disease control rate of 92%.</li><li>For 13 evaluable patients with non-small cell lung cancer, receiving 960 mg, seven (54%) achieved a partial response at one or  more timepoints, and six achieved stable disease.</li><li>AMG 510 continues to be well-tolerated with no dose-limiting toxicities.</li><li>Amgen is initiating combination studies to further explore potential of AMG 510 in lung and colorectal tumors.</li><li>Mirati Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRTX' title='Mirati Therapeutics, Inc.'>MRTX</a>), which has a similar molecule called MRTX849, is <font color=\"red\">falling 2.2%</font> in premarket action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502542\" data-linked=\"Amgen -2.0% after early stage AMG 510 data disappoints\" data-tweet=\"$AMGN $MRTX - Amgen -2.0% after early stage AMG 510 data disappoints https://seekingalpha.com/news/3502542-amgenminus-2_0-after-early-stage-amg-510-data-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3502542-amgenminus-2_0-after-early-stage-amg-510-data-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502540\" data-ts=\"1569843628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWL\" target=\"_blank\">NWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502540-newell-brandsplus-3-after-suntrust-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newell Brands +3% after SunTrust upgrade</a></h4><ul> <li>SunTrust Robinson Humphrey lifts Newell Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a>) to a Buy rating after having the consumer products maker slotted at Hold.</li> <li>The firm thinks Newell is on the verge of a turnaround and likes the current valuation on shares.</li> <li>SunTrust hikes its price target to $25 from $15 vs. the <a href=\"https://seekingalpha.com/symbol/NWL/ratings/sell-side-ratings\" target=\"_blank\">sell-side consensus PT</a> of $18.38.</li> <li>Shares of Newell Brands are <font color=\"green\">up 2.80%</font> premarket to $18.71.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502540\" data-linked=\"Newell Brands +3% after SunTrust upgrade\" data-tweet=\"$NWL - Newell Brands +3% after SunTrust upgrade https://seekingalpha.com/news/3502540-newell-brandsplus-3-after-suntrust-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3502540-newell-brandsplus-3-after-suntrust-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502535\" data-ts=\"1569843111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502535-bed-bath-beyond-rallies-after-wedbush-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond rallies after Wedbush upgrade</a></h4><ul> <li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) breaks higher after catching an upgrade from Wedbush to an Outperform rating.</li> <li>The firm is optimistic that Bed Bath &amp; Beyond will see earnings improvement over the next few years as a turnaround takes hold. The sale of real estate and non-core assets is also seen improving the financial picture.</li><li>The <a href=\"https://seekingalpha.com/symbol/BBBY/ratings/sell-side-ratings\" target=\"_blank\">consensus sell-side rating</a> on Bed Bath &amp; Beyond is Hold.</li> <li>Shares of BBBY are <font color=\"green\">up 3.54%</font> premarket to $10.24 vs. the 52-week trading range of $7.31 to $19.57.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502535\" data-linked=\"Bed Bath &amp; Beyond rallies after Wedbush upgrade\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond rallies after Wedbush upgrade https://seekingalpha.com/news/3502535-bed-bath-beyond-rallies-after-wedbush-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3502535-bed-bath-beyond-rallies-after-wedbush-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502534\" data-ts=\"1569842845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CI\" target=\"_blank\">CI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502534-bmo-turns-bullish-on-cigna-ciplus-1_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMO turns bullish on Cigna; CI +1.7%</a></h4><ul><li>BMO upgrades Cigna (NYSE:<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a>) from Market Perform to Outperform with a $188 price target.</li><li>The firm cites CI's lower valuation and a \"business mix that we think provides a \u2018hedge\u2019 against uncertain election outcomes.\"</li><li>CI shares are <font color=\"green\">up 1.7%</font> pre-market to $152. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/CI/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502534\" data-linked=\"BMO turns bullish on Cigna; CI +1.7%\" data-tweet=\"$CI - BMO turns bullish on Cigna; CI +1.7% https://seekingalpha.com/news/3502534-bmo-turns-bullish-on-cigna-ciplus-1_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3502534-bmo-turns-bullish-on-cigna-ciplus-1_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502533\" data-ts=\"1569842748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THO\" target=\"_blank\">THO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502533-thor-industries-cites-improvement-in-fq4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thor Industries cites improvement in FQ4</a></h4><ul> <li>Thor Industries (NYSE:<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a>) reports sales rose 23.3% in <a href=\"https://seekingalpha.com/pr/17647068-thor-announces-financial-results-fourth-quarter-fiscal-year-2019\" target=\"_blank\">FQ4</a> to $2.31B as the inclusion of the European RV segment was partially offset by a 17.6% drop in North American Towable RV sales and an 8.1% decrease in North American Motorized RV sales.</li> <li>Gross margin improved 140 bps during the quarter to 14.4%, reflecting favorable product mix as well as labor and warranty cost percentage improvements.</li> <li>\"We are encouraged by the improvement in the North American RV Towables segment in the fourth quarter, as we saw our flexible business model and the benefits of our variable cost structure drive improvement in margins for the quarter,\" notes Thor CEO Bob Martin.</li><li>Shares of Thor are <font color=\"red\">down 1.88%</font> premarket to $48.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3502524-thor-eps-beats-0_27-misses-revenue\" target=\"_blank\">Thor EPS beats by $0.27, misses on revenue</a> (Sept. 30)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502533\" data-linked=\"Thor Industries cites improvement in FQ4\" data-tweet=\"$THO - Thor Industries cites improvement in FQ4 https://seekingalpha.com/news/3502533-thor-industries-cites-improvement-in-fq4?source=tweet\" data-url=\"https://seekingalpha.com/news/3502533-thor-industries-cites-improvement-in-fq4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502529\" data-ts=\"1569842299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPG\" target=\"_blank\">SPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502529-forever-21-joins-mall-graveyard\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Forever 21 joins the mall graveyard</a></h4><ul> <li>Mall retailer Forever 21 officially files for bankruptcy.</li> <li>The company says the restructuring will allow it to focus on the profitable core part of its operations and shut some international locations.</li> <li>\"We have requested approval to close up to 178 stores across the U.S. The decisions as to which domestic stores will be closing are ongoing, pending the outcome of continued conversations with landlords,\" reads a Forever 21 statement.</li> <li>Forever 21 is Simon Property Group's (NYSE:<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a>) seventh-largest in-line tenant in terms of how much rent it brings the landlord, with 99 stores across its portfolio.</li> <li>Shares of SPG are <font color=\"red\">down 1.87%</font> premarket to $155.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3502529\" data-linked=\"Forever 21 joins the mall graveyard\" data-tweet=\"$SPG - Forever 21 joins the mall graveyard https://seekingalpha.com/news/3502529-forever-21-joins-mall-graveyard?source=tweet\" data-url=\"https://seekingalpha.com/news/3502529-forever-21-joins-mall-graveyard\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502526\" data-ts=\"1569841625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502526-spotify-bull-says-oversold-expects-video-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spotify bull says oversold, expects video partnership</a></h4><ul><li>Rosenblatt analyst Mark Zgutowicz says Spotify (NYSE:<a href='https://seekingalpha.com/symbol/SPOT' title='Spotify Technology S.A.'>SPOT</a>) shares are oversold following the recent pullback with shares down nearly 30% since an August peak.</li><li>The analyst expects SPOT to announce a video partnership, which would serve as a positive catalyst and help \"overcome long-term scale concerns.\"</li><li>Rosenblatt maintains a Buy rating and $184 price target. SPOT has an Outperform average <a href=\"https://seekingalpha.com/symbol/SPOT/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Spotify shares are <font color=\"green\">up 1.5%</font> pre-market to $113.89.</li></ul><div class=\"tiny-share-widget\" data-id=\"3502526\" data-linked=\"Spotify bull says oversold, expects video partnership\" data-tweet=\"$SPOT - Spotify bull says oversold, expects video partnership https://seekingalpha.com/news/3502526-spotify-bull-says-oversold-expects-video-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3502526-spotify-bull-says-oversold-expects-video-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3502520\" data-ts=\"1569840830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALM\" target=\"_blank\">CALM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3502520-cal-maine-foods-egg-sales-rose-1_7-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cal-Maine Foods&#39; egg sales rose 1.7% in Q1</a></h4><ul><li>Cal-Maine Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/CALM' title='Cal-Maine Foods, Inc.'>CALM</a>) reports egg sales rose 1.7% Y/Y to 254.424M in <a href=\"https://seekingalpha.com/pr/17647059-cal-maine-foods-reports-first-quarter-fiscal-2020-results\" target=\"_blank\">Q1</a>.</li><li>Specialty-egg sales accounted for 44.9% of total revenue, up 1070 bps Y/Y reflecting less volatility in the average selling price for specialty eggs.</li><li>Average price down 30% to $0.915 per dozen.</li><li>The average selling price for specialty eggs fell 1.4% to $1.863 per dozen.</li><li>The Southeast large market average price for conventional eggs dropped 40.7%.</li><li>SG&amp;A expense rate up 450 bps to 17.6%.</li><li>Pursuant to the quarterly loss, the Company has cut the dividend until a subsequent profitable quarter. Their policy is to pay one-third of the quarterly income as cash dividend.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3502518-cal-maine-foods-eps-line-misses-revenue\" target=\"_blank\">Cal-Maine Foods EPS in-line, misses on revenue</a> (Sept. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3502520\" data-linked=\"Cal-Maine Foods&#39; egg sales rose 1.7% in Q1\" data-tweet=\"$CALM - Cal-Maine Foods&#39; egg sales rose 1.7% in Q1 https://seekingalpha.com/news/3502520-cal-maine-foods-egg-sales-rose-1_7-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3502520-cal-maine-foods-egg-sales-rose-1_7-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 AM </div></div></li>","count":52,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}